Tag: widely

  • Why Testosterone Replacement Therapy (TRT) Is Surging in Popularity—And What You Should Know Before Considering It – Health Cages

    Why Testosterone Replacement Therapy (TRT) Is Surging in Popularity—And What You Should Know Before Considering It – Health Cages

    Over the past decade, testosterone replacement therapy (TRT) has shifted from a relatively obscure treatment to a widely discussed option for men seeking to improve their health, energy, and quality of life. What was once confined to specialty clinics and niche bodybuilding communities is now being openly discussed on mainstream platforms. High-profile figures like Joe Rogan have played a significant role in bringing TRT into the public eye—talking candidly about how it has helped with vitality, strength, and mental sharpness well into middle age.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    But the growing interest in TRT isn’t just about celebrity endorsements. It reflects a broader cultural shift. More men are taking their health seriously, getting routine bloodwork, and being proactive about symptoms they once ignored—fatigue, low libido, weight gain, poor sleep, irritability, and the dreaded “brain fog.” These are all potential indicators of low testosterone, a condition that becomes more common with age but is now being identified and addressed earlier thanks to greater awareness and better access to testing.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    The Science Behind the Trend

    (adsbygoogle=window.adsbygoogle||[]).push({})

    Testosterone is a key hormone involved in everything from muscle mass and fat distribution to mood, energy, and sexual function. As men age, testosterone levels naturally decline—typically about 1% per year after age 30. For some, this drop is gradual and manageable. But for others, especially those with underlying health issues or lifestyle stressors, low testosterone can cause more noticeable symptoms and lead to a reduced quality of life.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    That’s where TRT comes in. By restoring testosterone to optimal levels through injections, gels, or other delivery methods, many men report significant improvements in energy, motivation, sexual health, and overall well-being. For men with clinically low levels confirmed by lab testing, TRT isn’t just a shortcut to feeling younger—it’s a medically sound way to restore hormonal balance.

    What’s Fueling the Surge in Popularity?

    (adsbygoogle=window.adsbygoogle||[]).push({})

    Aside from cultural and medical awareness, a few practical factors have contributed to TRT’s rise:

    • Accessible Testing – Routine lab panels now often include testosterone levels, and many clinics or telehealth services offer easy, affordable testing.
    • Improved Treatment Protocols – With better delivery methods (like bioavailable injections) and individualized dosing, TRT has become more effective and manageable.
    • Changing Perception – Once stigmatized or viewed as “just for bodybuilders,” TRT is increasingly seen as a valid option for everyday men who want to feel their best.

    Even so, there’s still a fair amount of confusion and misinformation about TRT, especially online. Some men jump into treatment without fully understanding what it involves, while others avoid it entirely due to outdated fears or myths. That’s why it’s so important to get educated and work with a provider who specializes in hormone therapy.

    The Questions Men Should Be Asking

    If you’re starting to consider TRT—or have been curious after hearing about it in podcasts, YouTube videos, or discussions with friends—there are some key things to understand before making a decision. How do TRT injections work? What are the potential side effects? How long does it take to feel results? Will it impact fertility or long-term health?

    These are just a few of the commonly asked questions about TRT injections that are important to explore. Having clear, medically backed answers can help you make an informed choice and avoid common mistakes—like starting TRT without proper labs, ignoring lifestyle factors, or failing to monitor key markers like estrogen levels and red blood cell count during treatment.

    TRT: A Tool, Not a Magic Bullet

    It’s worth noting that while TRT can offer tremendous benefits for the right candidates, it’s not a cure-all. Hormone therapy should always be part of a larger health strategy that includes proper nutrition, strength training, stress management, and sleep optimization. When used responsibly and under medical supervision, TRT can be a powerful tool—but it works best when combined with healthy habits.

    The growing popularity of TRT is ultimately a reflection of something much bigger: men becoming more proactive, more informed, and more engaged in their health than ever before. That’s a trend worth supporting.

     

  • Ecosia has offered to take ‘stewardship’ of Chrome. And it's not a bad idea.

    Ecosia has offered to take ‘stewardship’ of Chrome. And it's not a bad idea.

    “It’s not absurd, right?” Christian Kroll, CEO of Berlin-based nonprofit search engine Ecosia, says of his company’s unsolicited request to be granted a 10-year “stewardship” of Google’s Chrome browser, instead of forcing Google to sell it to a competitor.

    His idea is most definitely absurd, but also clever.

    On Thursday, Ecosia announced it had sent a proposal regarding Chrome to Google and to U.S. Judge Amit Mehta. The judge is expected to rule this month on remedies to his 2024 landmark decision that Google has an illegal monopoly in internet search and advertising. 

    One of the remedies the Department of Justice asked for would force Google to divest itself from Chrome. Google has not agreed to do so (and in 2024 vowed to appeal the original ruling). Still, competitors have been lining up to buy Chrome ever since. Both OpenAI and Perplexity have said they’d buy it; last week Perplexity even made an unsolicited $34.5 billion cash offer.

    Perplexity’s offer was widely panned as being too low (not to mention, billions more than Perplexity has raised to date). “We’d think OpenAI potentially would be prepared to pay significantly more for it,” speculated RBC analyst Brad Erickson in a research note.

    Ecosia believes Chrome is on track to generate $1 trillion over the next decade and an auction could price it “in the hundreds of billions,” Kroll says.

    Which is why, on face value, Ecosia asking to be handed Chrome for free — including control of about 60% of the revenue generated by its users — seems absurd. 

    Techcrunch event

    Tech and VC heavyweights join the Disrupt 2025 agenda

    Netflix, ElevenLabs, Wayve, Sequoia Capital, Elad Gil — just a few of the heavy hitters joining the Disrupt 2025 agenda. They’re here to deliver the insights that fuel startup growth and sharpen your edge. Don’t miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $600+ before prices rise.

    Tech and VC heavyweights join the Disrupt 2025 agenda

    Netflix, ElevenLabs, Wayve, Sequoia Capital — just a few of the heavy hitters joining the Disrupt 2025 agenda. They’re here to deliver the insights that fuel startup growth and sharpen your edge. Don’t miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $675 before prices rise.

    San Francisco
    |
    October 27-29, 2025

    REGISTER NOW

    The proposal promises to spend those billions on climate projects, as is Ecosia’s general mission. Founded in 2009, the nonprofit donates millions per month and has relationships with local communities and NGOs in over 35 countries. It has specified projects in this Chrome proposal, including protecting rainforests, global tree-planting and agroforestry, prosecuting polluters, and investing in green AI tech.

    The remaining 40% ($400 billion, Ecosia says, based on that $1 trillion estimate) would be paid to Google. Google would maintain intellectual property ownership, and can even continue to be the default search engine. When the decade is up, stewardship could be passed to another, or otherwise reviewed.

    Ecosia, which uses Google to power its search engine, already has a revenue-share partnership with the tech giant. And it already offers its own browser built on the Chromium open source engine that powers Chrome. That’s why Kroll thinks the stewardship idea isn’t so out-of-line. “We would be happy to manage Chrome for them,” he says. Ecosia is even offering to maintain employment for the Chrome staff.

    Still, Kroll admits the bigger goal is to get the judge to consider alternatives to the typical divesture options of selling or spinning off. Those options would simply keep Chrome’s power, and its billions, in the pockets of big tech.

    “We hold a track record of making impossible things possible,” he says. Should he get the judge thinking, “who knows what might come out of it?”

    We’re always looking to evolve, and by providing some insight into your perspective and feedback into TechCrunch and our coverage and events, you can help us! Fill out this survey to let us know how we’re doing and get the chance to win a prize in return!